CAMBRIDGE - Even before its 2001 founding, the story of Momenta Pharmaceuticals Inc. perfectly showcased the Massachusetts biomedical start-up ecosystem at work. It was born in MIT labs, where scientists developed a breakthrough process for understanding the structure of complex sugars. It was funded by a high-powered investor group led by Waltham’s Polaris Venture Partners. And it tapped into the star power of Boston’s world-famous medical institutions to assemble its scientific advisory board.
BostonGlobe.comSubscriber Log-in
Contact us for help
-
Phone
617-929-2233
Daily 8 a.m.-7 p.m.
-
Chat
Daily 7 a.m.-7 p.m.


Comments